Fortis Group Advisors, LLC Precigen, Inc. Transaction History
Fortis Group Advisors, LLC
- $504 Billion
- Q2 2024
A detailed history of Fortis Group Advisors, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 18,966 shares of PGEN stock, worth $30,724. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,966
Previous 18,966
-0.0%
Holding current value
$30,724
Previous $27.5 Million
8.96%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding PGEN
# of Institutions
145Shares Held
145MCall Options Held
208KPut Options Held
43.7K-
Third Security, LLC83.5MShares$135 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.5MShares$28.3 Million1.27% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$16.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.77MShares$11 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.03MShares$4.91 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $337M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...